Increase of 1-year Mortality After Perioperative Beta-blocker Withdrawal in Endovascular and Vascular Surgery Patients

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 1, 2007, Pages 13-19

  Hoeks, S E ^a   Scholte op Reimer, W J M ^a   van Urk, H ^a   Jorning P J G ^b   Boersma, E ^a   Simoons, M L ^a   Bax, J J ^c   Poldermans, D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c Leiden MC ^*  (Netherlands)

Author keywords

Beta blocker withdrawal; Beta blockers; Peripheral vascular disease; Prognosis; Risk stratification

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOVASCULAR SURGERY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NETHERLANDS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY; CARDIOVASCULAR DISEASES; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; NETHERLANDS; ODDS RATIO; PERIOPERATIVE CARE; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 33845210865     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.06.019     Document Type: Article

References (25)

1. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 72 (1990) 153-184
2. Jamieson W.R.J.M., Miyagishima R.T., and Gerein A.N. Influence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease. Circulation 66 (1982) I92-I97
3. McFalls E., Ward H., Santilli S., Scheftel M., Chesler E., and Doliszny K. The influence of perioperative myocardial infarction on long-term prognosis following elective vascular surgery. Chest 113 (1998) 681-686
4. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39 (2002) 542-553
5. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
6. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 (1999) 1789-1794
7. Shammash J.B., Trost J.C., Gold J.M., Berlin J.A., Golden M.A., and Kimmel S.E. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 141 (2001) 148-153
8. Goldman L. Noncardiac surgery in patients receiving propranolol. Case reports and recommended approach. Arch Intern Med 141 (1981) 193-196
9. Frishman W.H. Beta-adrenergic blocker withdrawal. Am J Cardiol 59 (1987) 26F-32F
10. Psaty B.M., Koepsell T.D., Wagner E.H., LoGerfo J.P., and Inui T.S. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA 263 (1990) 1653-1657
11. Langou R.A., Wiles J.C., Peduzzi P.N., Hammond G.L., and Cohen L.S. Incidence and mortality of perioperative myocardial infarction in patients undergoing coronary artery bypass grafting. Circulation 56 (1977) II54-II58
12. Karachalios G.N., Charalabopoulos A., Papalimneou V., Kiortsis D., Dimicco P., Kostoula O.K., et al. Withdrawal syndrome following cessation of antihypertensive drug therapy. Int J Clin Pract 59 (2005) 562-570
13. Schmidt M., Lindenauer P.K., Fitzgerald J.L., and Benjamin E.M. Forecasting the impact of a clinical practice guideline for perioperative beta-blockers to reduce cardiovascular morbidity and mortality. Arch Intern Med 162 (2002) 63-69
14. Rapchuk I., Rabuka S., and Tonelli M. Perioperative use of beta-blockers remains low: experience of a single Canadian tertiary institution. Can J Anaesth 51 (2004) 761-767
15. Lindenauer P.K., Fitzgerald J., Hoople N., and Benjamin E.M. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med 164 (2004) 762-766
16. VanDenKerkhof E.G., Milne B., and Parlow J.L. Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of Canadian anesthesiologists. Anesth Analg 96 (2003) 1558-1565
17. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
18. Lenzen M.J., Boersma E., Reimer W.J., Balk A.H., Komajda M., Swedberg K., et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 26 (2005) 2706-2713
19. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.-A.C., et al. Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement. JAMA 282 (1999) 1458-1465
20. Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., and Benjamin E.M. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
21. Poldermans D., and Boersma E. Beta-blocker therapy in noncardiac surgery. N Engl J Med 353 (2005) 412-414
22. Fernando S.K., and Atlas S.A. Increasing perioperative beta-blocker utilization: A successful quality improvement project. Am J Med 118 (2005) 802-803
23. Armanious S., Wong D.T., Etchells E., Higgins P., and Chung F. Successful implementation of perioperative beta-blockade utilizing a multidisciplinary approach: [L'application reussie d'un beta-blocage perioperatoire par une approche multidisciplinaire]. Can J Anesth 50 (2003) 131-136
24. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 357 (2001) 995-1001
25. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281